Insider · CIK 0002037713
Christian Behrenbruch
Files at TLX (Telix Pharmaceuticals Ltd). First filing May 6, 2026, latest May 6, 2026.
Christian Behrenbruch files SEC Form 4 as CEO and director at TLX (Telix Pharmaceuticals Ltd). Since May 6, 2026, Christian Behrenbruch has reported 1 open-market buy worth $997k and 0 open-market sells worth $0, the latest filed on May 6, 2026.
A track record needs three past buys with six months of prices behind them; Christian Behrenbruch has 0, so none is measured yet.
The newest scored trade: bought $997k of TLX on Apr 28, 2026, filed May 6, 2026, scored 53 (moderate). In the last 12 months: 1 buy worth $997k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TLX: Telix Pharmaceuticals Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | TLXbuy Telix Pharmaceuticals Ltd | $997k 67,935 shares | +0% | +63% from low-44% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TLX Telix Pharmaceuticals Ltd | POpen-market purchase Ordinary Sharesindirect: Elk River Holdings Pty Ltd | +34,500 | $14.48 | $500k | 20,709,500 | May 6, 2026 |
| Apr 29, 2026 | TLX Telix Pharmaceuticals Ltd | POpen-market purchase Ordinary Sharesindirect: Elk River Holdings Pty Ltd | +33,435 | $14.87 | $497k | 20,742,935 | May 6, 2026 |
Questions about Christian Behrenbruch
Answered from the filings on this page, as of the latest one.
Is Christian Behrenbruch buying or selling?
In the last 12 months Christian Behrenbruch reported 1 open-market buy worth $997k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $997k of TLX on Apr 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Christian Behrenbruch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christian Behrenbruch has 0.
Where does Christian Behrenbruch file Form 4?
Christian Behrenbruch has filed Form 4 at TLX (Telix Pharmaceuticals Ltd) as MD & Group CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.